Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,800 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 October 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 4MB, 241 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 45 results:
Author Title Type [ Year(Asc)]
Filters: Author is Filion, K. B.  [Clear All Filters]
2021
S. M. Grandi, Filion, K. B., Hutcheon, J. A., Rosella, L. C., and Platt, R. W., Accounting for Repeat Pregnancies in Risk Prediction Models, Epidemiology, 2021.
C. R. Dormuth, Winquist, B., Fisher, A., Wu, F., Reynier, P., Suissa, S., Dahl, M., Ma, Z., Lu, X., Zhang, J., Raymond, C. B., Filion, K. B., Platt, R. W., Moriello, C., and Paterson, J. M., Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort, JAMA Netw Open, vol. 4, p. e215329, 2021.
V. C. Brunetti, Yu, O. H. Y., Platt, R. W., and Filion, K. B., Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018, Diabet Med, p. e14603, 2021.
K. Suissa, Schneeweiss, S., Douros, A., Filion, K. B., Yin, H., Patorno, E., and Azoulay, L., The modifying effects of adiposity on the cardiovascular safety of sulphonylureas, Diabetes Obes Metab, 2021.
T. Jiao, Platt, R. W., Douros, A., and Filion, K. B., Prescription Patterns for the Use of Antihypertensive Drugs for Primary Prevention among Patients with Hypertension in the United Kingdom, Am J Hypertens, 2021.
V. C. Brunetti, Reynier, P., Azoulay, L., Yu, O. H. Y., Ernst, P., Platt, R. W., and Filion, K. B., SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study, Pharmacoepidemiol Drug Saf, 2021.
Y. H. Yu, Filion, K. B., Reynier, P., Platt, R. W., Yu, O. H. Y., and Grandi, S. M., Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population-based assessment, Pharmacol Res Perspect, vol. 9, p. e00848, 2021.
A. Douros, Cui, Y., Platt, R. W., Filion, K. B., Sebastiani, G., and Renoux, C., Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease, Br J Clin Pharmacol, 2021.
L. M. Lix, Sobhan, S., St-Jean, A., Daigle, J. M., Fisher, A., Yu, O. H. Y., Dell'Aniello, S., Hu, N., Bugden, S. C., Shah, B. R., Ronksley, P. E., Alessi-Severini, S., Douros, A., Ernst, P., and Filion, K. B., Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study, BMC Health Serv Res, vol. 21, p. 758, 2021.
2019
A. Douros, Rouette, J., Yin, H., Yu, O. H. Y., Filion, K. B., and Azoulay, L., Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes, Diabetes Care, 2019.
M. Eberg, Platt, R. W., Reynier, P., and Filion, K. B., Estimation of high-dimensional propensity scores with multiple exposure levels, Pharmacoepidemiol Drug Saf, 2019.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research, Pharmacoepidemiol Drug Saf, 2019.
M. H. Secrest, Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., and Filion, K. B., Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example, Pharmacoepidemiol Drug Saf, 2019.
C. E. Lefebvre, Filion, K. B., Reynier, P., Platt, R. W., and Zappitelli, M., Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD, Clin J Am Soc Nephrol, 2019.
K. B. Filion, Douros, A., Azoulay, L., Yin, H., Yu, O. H., and Suissa, S., Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study, Br J Clin Pharmacol, 2019.
2018
B. M. Hicks, Filion, K. B., Yin, H., Sakr, L., Udell, J. A., and Azoulay, L., Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study, Bmj, vol. 363, p. k4209, 2018.
A. Mehrabadi, Reynier, P., Platt, R. W., and Filion, K. B., Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1316-1324, 2018.
A. Douros, Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., and Azoulay, L., Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy, Diabetes Care, vol. 41, pp. 2330-2338, 2018.
O. Yu, Azoulay, L., Yin, H., Filion, K. B., and Suissa, S., Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia, Am J Med, vol. 131, pp. 317.e11-317.e22, 2018.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study, Bmj, vol. 362, p. k2693, 2018.
S. M. Grandi, Reynier, P., Platt, R. W., Basso, O., and Filion, K. B., The timing of onset of hypertensive disorders in pregnancy and the risk of incident hypertension and cardiovascular disease, Int J Cardiol, vol. 270, pp. 273-275, 2018.
2017
N. Larivee, Suissa, S., Eberg, M., Joseph, L., Eisenberg, M. J., Abenhaim, H. A., and Filion, K. B., Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study, Bjog, vol. 124, pp. 1672-1679, 2017.
N. Larivee, Suissa, S., Coulombe, J., Tagalakis, V., and Filion, K. B., Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters, Drug Saf, vol. 40, pp. 583-596, 2017.
M. Eberg, Platt, R. W., and Filion, K. B., The Estimation of Gestational Age at Birth in Database Studies, Epidemiology, vol. 28, pp. 854-862, 2017.
S. M. Grandi, Vallee-Pouliot, K., Reynier, P., Eberg, M., Platt, R. W., Arel, R., Basso, O., and Filion, K. B., Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease, Paediatr Perinat Epidemiol, vol. 31, pp. 412-421, 2017.
A. Douros, Yin, H., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events, Diabetes Care, vol. 40, pp. 1506-1513, 2017.
J. Y. Shin, Eberg, M., Ernst, P., and Filion, K. B., Statin potency and the risk of hospitalization for community-acquired pneumonia, Br J Clin Pharmacol, vol. 83, pp. 1319-1327, 2017.
[Page last reviewed 5 October 2021]